Company / Gross Margin
Bristol Myers Squibb Gross Margin History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
72.3%
FY2020
5-year range
-
FY2016-FY2020
Trend
-6.6%
vs FY2019
Sector context
#12 of 28
Health Care
What the data says
At 72.3%, Bristol Myers Squibb's gross margin ranks #12 of 28 in the Health Care sector. Declined from 75.6% to 72.3% over the past 2 years.
Based on SEC 10-K filings.
72.3% in FY2020 with a 3-year CAGR of +1.6%.
Declined from 75.6% to 72.3% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +1.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#12 of 28 in Health CareTop 43% of 28This company 72.3% Sector average 60.3%
▼
+19.9% above sector average
Key checks
Key Insights
- In FY2020, gross margin decreased 6.6% year-over-year.
- Currently 12.0pp above the Health Care sector average.
- Peak gross margin was recorded in FY2016.
- Lowest gross margin in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | 72.3% | -6.6% |
| FY2019 | 77.5% | +2.5% |
| FY2018 | 75.6% | +6.9% |
| FY2017 | 70.7% | -11.3% |
| FY2016 | 79.7% | +9.3% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026